Bacterial colonization of chronic wounds. Studies on outpatients in a university dermatology clinic with special consideration of ORSA;Bakterielle kolonisation chronischer wunden. Untersuchungen in einer universitären dermatologischen wundambulanz unter besonderer berücksichtigung von ORSA

Hautarzt

Volumn 55, Issue 3, 2004, Pages 280-288

  Dissemond, J ^a   Schmid, E N ^a   Esser, S ^a   Witthoff, M ^a   Goos, M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Chronic wounds; MRSA; ORSA; Wound healing

Indexed keywords

AMIKACIN; AMPICILLIN; CEFUROXIME; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; OXACILLIN; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CANDIDA PARAPSILOSIS; CHRONIC DISEASE; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT; OXACILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SERRATIA MARCESCENS; SKIN INJURY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; WOUND HEALING;

AGED; AGED, 80 AND OVER; BACTERIOLOGICAL TECHNIQUES; CHRONIC DISEASE; CLINDAMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; FEMALE; FOOT ULCER; GENTAMICINS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OXACILLIN; PENICILLIN RESISTANCE; PRESSURE ULCER; RADIODERMATITIS; SKIN DISEASES, BACTERIAL; SKIN ULCER; STAPHYLOCOCCAL SKIN INFECTIONS; TETRACYCLINE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VANCOMYCIN; VANCOMYCIN RESISTANCE; VARICOSE ULCER; WOUND INFECTION;

EID: 1642423709     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-004-0697-4     Document Type: Article

References (35)

1. Anonymous (1997) Reduced susceptibility of Staphylococcus aureus to vancomycin-Japan, 1996. MMWR Morb Mortal Wkly Rep 46:624-626
2. Anonymous (2002) Staphylococcus aureus resistant to vancomycin-United States 2002. MMWR Morb Mortal Wkly Rep 51:565-567
3. Bowler PG, Davies BJ (1999) The microbiology of infected and noninfected leg ulcers. Int J Dermatol 38:573-578
4. Bowler PG, Duerden BI, Armstrong DG (2001) Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 14:244-269
5. Colsky AS, Kirsner RS, Kerdel FA (1998) Analysis of antibiotic susceptibilities of wound flora in hospitalised dermatology patients: the crisis of antibiotic resistance has come to the surface. Arch Dermatol 134:1006-1009
6. Cosgrove SE, Sakoulas G, Perencevich EN et al. (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53-59
7. Frenay HM, Vandenbrocke-Grauls, CM, Molkenboer MJ, Verhoef J (1992) Long-term carriage, and transmission of methicillin-resistant Staphylococcus aureus after discharge from hospital. J Hosp Infect 22:207-215
8. Gillitzer R (2002) Modernes Wundmanagement. Hautarzt 53:130-147
9. Gonzalez-Zorn B, Courvalin P (2003) vanA-mediated high level glycopeptide resistance in MRSA. Lancet Infect Dis 3:67-68
10. Grohs P, Kitzis MD, Gutmann L (2003) In vitro bactercidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against staphylococcus aureus. Antimicrob Agents Chemother 47:418-420
11. Halbert AR, Stacey MC, Rohr JB, Jopp-McKay A (1992) The effect of bacterial colonization on venous ulcer healing. Australas J Dermatol 33:75-80
12. Hansson C, Hoborn J, Moller A, Swanbeck G (1995) The microbial flora in venous leg ulcers without clinical signs of infection. Repeated culture using a validated standardised microbiological technique. Acta Derm Venereol 75:24-30
13. Hernandez R (1999) Systemic antibiotics: a review and their use in chronic wounds. Dermatol Ther 9:44-62
14. Hoeger PH, Lenz W, Boutonnier A, Fournier JM (1992) Staphylococcal skin colonization in children with atopic dermatitis: prevalence, and transmission of toxic and nontoxic strains. J Infect Dis 165:1064-1068
15. Huang SS, Platt R (2003) Risk of methicillin-resistant staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 36:281-285
16. Jevons MP (1961) Celbenin resistant staphylococci. Br Med J 1:124-125
17. Kac G, Buu-Hoi A, Herisson E et al. (2000) Methicillin-resistent staphylococcus aureus. Nosocomial acquisition and carrier state in a wound care center. Arch Dermatol 136:735-739
18. König DP, Randerath O, Hackenbroch MH (1999) Nosokomiale Infektionen mit Methicillin-resistenten Staphylococcus aureus (MRSA) und epidermidis (MRSE) Stämmen. Unfallchirurg 102:323-328
19. Linde HJ, Lehn N (2002) Methicillin-resistenter Staphylococcus aureus (MRSA). Hautarzt 53:690-701
20. Muder RR, Brennen C, Wagener MM et al. (1991) Methicillin-resistant Staphylococcal colonisation and infection in a long-term care facility. Ann Intern Med 114:107-112
21. O'Meara S, Cullum N, Majid M, Sheldon T (2000) Systemic review of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration. Health Technol Assessment 4:1-237
22. Paladino JA (2002) Linezolid: an oxazolidinone antimicrobial agent. Am J Health Syst Pharm 59:2413-2425
23. Paradisi F, Corti G, Messeri D (2001) Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics. Med Clin North Am 85:1-17
24. Pathare NA, Bal A, Talvalkar GV, Antani DU (1998) Diabetic foot infections: a study of microorganisms associated with the different Wagner grades. Indian J Pathol Microbiol 41:437-441
25. Pittet D, Hugonnet S, Harbarth S et al. (2000) Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 356:1307-1312
26. Pujol M, Pena C, Pallares R et al. (1996) Nosocomial Staphylococcus aureus bacteriemia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 100:509-516
27. RKI (1998) Erstes Auftreten von MRSA mit verminderter Glykopeptidresistenz in Deutschland nachgewiesen. Epidem Bull RKI 17:123
28. Roghmann MC, Siddiqui A, Plasance K, Standiford H (2001) MRSA colonization and the risk of MRSA bacteriemia in hospitalized patients with chronic ulcers. J Hosp Infect 47:98-103
29. Scharffetter-Kochanek K, Schüller J, Meewes C et al. (2003) Das chronisch venöse Ulcus cruris. JDDG 1:58-67
30. Schneider C, Weindel M, Brade V (1996) Frequency, clonal heterogenety and antibiotic resistance of methicillin-resistant Staphylococcus aureus (MRSA) isolated in 1992-1994. Zbl Bakt 283:529-542
31. Sieradzki K, Roberts RB, Haber SW, Tomasz A (1999) The development of vancomycin resistance in a patient with methicillin-resistance Staphylococcus aureus infection. N Engl J Med 340:517-523
32. Tsiodras S, Gold HS, Sakoulas G et al. (2001) Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358:207-208
33. von Eiff C, Peters G (1999) Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci. J Antimicrobial Chemother 43:569-573
34. Voss A, Machka K, Lenz W, Milatovic D (1992) Vorkommen, Häufigkeit und Resistenzverhalten von Methicillin-resistenten Staphylococcus aureus Stämmen in Deutschland. Dtsch Med Wochenschr 117:1907-1912
35. Whitby M, McLaws ML, Berry G (2001) Risk of death from methicillin-resistant staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 175:264-267